Cargando…

Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study

OBJECTIVES: We explored efficacy and safety of IVIg as first-line treatment in patients with an idiopathic inflammatory myopathy. METHODS: In this investigator-initiated phase 2 open-label study, we included 20 adults with a newly diagnosed, biopsy-proven idiopathic inflammatory myopathy, and a dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Johan, Eftimov, Filip, Verhamme, Camiel, Brusse, Esther, Hoogendijk, Jessica E, Saris, Christiaan G J, Raaphorst, Joost, De Haan, Rob J, van Schaik, Ivo N, Aronica, Eleonora, de Visser, Marianne, van der Kooi, Anneke J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023983/ https://www.ncbi.nlm.nih.gov/pubmed/33099648 http://dx.doi.org/10.1093/rheumatology/keaa459

Ejemplares similares

Assessment of disability in idiopathic inflammatory myopathy: a call for linearity
por: Min, Minoesch, et al.
Publicado: (2021)

Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study
por: Walter, Anne W, et al.
Publicado: (2022)

Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review
por: Kamperman, Renske G., et al.
Publicado: (2022)

Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies
por: Lim, J., et al.
Publicado: (2019)

OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
por: Walter, Hannah A W, et al.
Publicado: (2021)

B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies
por: Anang, Dornatien C, et al.
Publicado: (2022)

Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial
por: Kamperman, Renske G, et al.
Publicado: (2023)

Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study
por: Lucke, Ilse M., et al.
Publicado: (2021)

Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy
por: Lim, Johan, et al.
Publicado: (2018)

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
por: Verhamme, Camiel, et al.
Publicado: (2009)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
por: van Paassen, Barbara W, et al.
Publicado: (2014)

Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma
por: van Dijk, Stefan, et al.
Publicado: (2016)

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study
por: Adrichem, M. E., et al.
Publicado: (2019)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
por: van Veen, Robin, et al.
Publicado: (2022)

Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study
por: Lim, Johan, et al.
Publicado: (2023)

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy
por: Eftimov, Filip, et al.
Publicado: (2020)

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
por: Bus, S. R. M., et al.
Publicado: (2021)

Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis
por: Beeldman, Emma, et al.
Publicado: (2020)

Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
por: Wieske, Luuk, et al.
Publicado: (2014)

The frontotemporal syndrome of ALS is associated with poor survival
por: Govaarts, Rosanne, et al.
Publicado: (2016)

Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
por: Almoallim, Hani, et al.
Publicado: (2023)

Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case–control Study
por: Seelen, Meinie, et al.
Publicado: (2017)

Early Prediction of Intensive Care Unit–Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study
por: Wieske, Luuk, et al.
Publicado: (2014)

Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study
por: Wieske, Luuk, et al.
Publicado: (2015)

Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
por: Witteveen, Esther, et al.
Publicado: (2017)

Assessment of intensive care unit‐acquired weakness in young and old mice: An E. coli septic peritonitis model
por: Witteveen, Esther, et al.
Publicado: (2015)

No association between gluten sensitivity and amyotrophic lateral sclerosis
por: Visser, Anne E., et al.
Publicado: (2017)

Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers
por: Schade van Westrum, Steven, et al.
Publicado: (2013)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
por: Farini, Andrea, et al.
Publicado: (2021)

Efficacy of a physical activity programme combining individualized aerobic exercise and coaching to improve physical fitness in neuromuscular diseases (I’M FINE): study protocol of a randomized controlled trial
por: Oorschot, Sander, et al.
Publicado: (2020)

Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementia
por: Govaarts, Rosanne, et al.
Publicado: (2022)

Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
por: van Lieverloo, G. G. A., et al.
Publicado: (2018)

Serum Contactin-1 in CIDP: A Cross-Sectional Study
por: Wieske, Luuk, et al.
Publicado: (2021)

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
por: van Spaendonck-Zwarts, K. Y., et al.
Publicado: (2012)

Late-onset myopathies: clinical features and diagnosis
por: de Visser, Marianne
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8vc5d530ojhi41tfujmdcll9ed